Although increasing lines of evidence have proved that the deviant expression of m6A modification may be the cause of tumor progression [13–15], the mechanism through which m6A regulators, especially IGF2BP3, function in NPC tumorigenesis remains unknown. This evidence concerns the gene IGF2BP3 and nasopharyngeal carcinoma.